Twitter Linked-in Infertility Youtube Pinterest Google Plus Facebook

Hormone Therapy For Menopause May Benefit Younger Women, Study Suggests.

November 12, 2015

Hormone Therapy For Menopause May Benefit Younger Women, Study Suggests.

Dr. Fox responds to the following article:

http://www.npr.org/sections/health-shots/2015/11/09/454710392/hormones-may-help-younger-women-with-menopause-symptoms

Here is more backpedaling from the WHI (Women’s health Initiative study; 2002) where the government spent 70 million dollars, scared an entire generation of women and doctors from using hormones only to now 13 years later recant most of what was earth shattering news in 2002. Go figure? Now after a second third etc., look at the data shows that for women aged 50-59 there is a beneficial effect for cardiovascular disease for women on oral Premarin and Provera (the only drugs studied). Today, in our practice we work hard not to use oral estrogens in women that are known to increasing clotting slightly and represent the cause of the brief 1-2 year increased risk of cardiovascular events seen in women over 60. Therefore, for the younger women, the benefit would increase dramatically with use of non oral estrogen. The latest sentiment from NAMS (North American Menopause Society) is start early and stay on it. We find that many women start having symptoms of estrogen deficiency as early as the late 30’s early 40’s and respond beautifully to estrogen supplementation at that time continuing the drug on into menopause. The WHI did not look at any premenopausal use of estrogen but would have found a much higher improvement had it studied that group. We encourage women to seek help as early as symptoms manifest. Symptoms include but are not limited to: anxiety, depression, mood changes, decreased libido, memory issues, attention problems, bloating, headaches, weight gain, hot flashes, night sweats, urinary frequency, urinary urgency, and vaginal dryness.

Michael D. Fox, MD
Jacksonville Center
Reproductive Medicine
jcrm.org

   
Go back to category:
[ssba]

Comments are closed.